More than three-quarters (78%) of B2B organizations are using marketing automation tools, according to recent research from Dun & Bradstreet and Ascend2. The report was based on data from a survey of ...
Pharmaceutical companies approach a significant wave of patent expirations by 2030. This includes exclusivity rights set to expire for 569 medications valued at $278 billion, based on 2022 sales.¹ As ...